Preoperative Treatment of Uterine Leiomyomas: Clinical Findings and Expression of Transforming Growth Factor-β3 and Connective Tissue Growth Factor

Journal of the Society for Gynecologic Investigation

Volumn 13, Issue 4, 2006, Pages 297-303

  De Falco, Marianna ^a   Staibano, Stefania ^a   D'Armiento, Francesco Paolo ^a   Mascolo, Massimo ^a   Salvatore, Gaetano ^a   Busiello, Anna ^a   Carbone, Ilma Floriana ^a   Pollio, Fabrizio ^a   Di Lieto, Andrea ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

CTGF; GnRH analog; TGF 3; tibolone; Uterine leiomyomas

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GONADORELIN DERIVATIVE; HEMOGLOBIN; IRON; LEUPRORELIN; TIBOLONE; TRANSFORMING GROWTH FACTOR BETA3; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; IMMEDIATE EARLY PROTEIN; PREGNANE DERIVATIVE; SIGNAL PEPTIDE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ARTICLE; BLOOD EXAMINATION; BONE DENSITY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ECHOGRAPHY; ENDOTHELIUM CELL; FEMALE; HEMOGLOBIN BLOOD LEVEL; HOT FLUSH; HUMAN; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IRON BLOOD LEVEL; LEIOMYOMA; MENORRHAGIA; MYOMA; MYOMETRIUM; PELVIS PAIN SYNDROME; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; UTERUS MYOMA; UTERUS SURGERY; VISUAL ANALOG SCALE; ADJUVANT THERAPY; BIOSYNTHESIS; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG COMBINATION; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION; UTERUS CANCER;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; BONE DENSITY; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBINS; HOT FLASHES; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOHISTOCHEMISTRY; INJECTIONS, SUBCUTANEOUS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON; LEIOMYOMA; LEUPROLIDE; MYOMETRIUM; NEOADJUVANT THERAPY; NORPREGNENES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA3; UTERINE NEOPLASMS;

EID: 33744984212     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsgi.2006.02.008     Document Type: Article

References (29)

1. Palomba S., Pellicano M., Affinito P., Di Carlo C., Zullo F., and Nappi C. Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy. Fertil Steril 75 (2001) 429-433
2. Palomba S., Affinito P., Di Carlo C., Bifulco G., and Nappi C. Long term administration of tibolone plus gonadotropin-releasing hormone agonist for treatment of uterine leiomyomas. Effectiveness and effects on vasomotor symptoms, bone mass, and lipid profile. Fertil Steril 72 (1999) 889-895
3. Chegini N., Ma C., Tang X.M., and Williams R.S. Effects of GnRH analogues, "add-back" steroid therapy, antiestrogen and antiprogestins on leiomyoma and myometrial smooth muscle cell growth and transforming growth factor-beta expression. Mol Hum Reprod 8 (2002) 1071-1078
4. Hulboy D.L., Rudolph L.A., and Matrisian L.M. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 3 (1997) 27-45
5. Ignotz R.A., and Massague J. Transforming growth factor-B stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261 (1986) 4337-4345
6. Bruner K.L., Rodgers W.H., Gold L.I., et al. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A 92 (1995) 7362-7366
7. Ma C., and Chegini N. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-β1. Mol Hum Reprod 5 (1999) 950-954
8. Derynck R., Lindquist P.B., Lee A., et al. A new type of transforming growth factor-β, TGF-β3. EMBO J 7 (1988) 3737-3743
9. Arici A., and Sozen I. Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation. Fertil Steril 73 (2000) 1006-1011
10. Dou Q., Tamuzzer R.W., Williams R.S., Schultz G.S., and Chegini N. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata. A mechanism for gonadotropin releasing hormone agonist-induced tumor regression. Mol Hum Reprod 3 (1997) 1005-1014
11. Dou Q., Zhao Y., Tarnuzzer R.W., et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropin-releasing hormone agonist therapy. J Clin Endocrinol Metab 81 (1996) 3222-3230
12. Pawar S., Kartha S., and Toback F.G. Differential gene expression in migrating renal epithelial cells after wounding. J Cell Physiol 165 (1995) 556-565
13. Xie S., Sukkar M.B., Issa R., Oltmanns U., Nicholson A.G., and Chung K.F. Regulation of TGF-beta 1-induced connective tissue growth factor expression in airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 288 (2005) L68-L76
14. Brigstock D.R. The connective tissue growth factor/cysteine-rich61/nephroblastoma overexpressed (CCN) family. Endocrine Rev 20 (1999) 189-206
15. Bradham D.M., Igarashi A., Potter R.L., and Grotendorst G.R. Connective tissue growth factor. A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 114 (1991) 1285-1294
16. Igarashi A., Okochi H., Bradham D.M., and Grotendorst G.R. Regulation of connective tissue growth factor gene expression in human skin fibroblasts during wound repair. Mol Biol Cell 4 (1993) 637-645
17. Igarashi A., Nashiro K., Kikuchi K., et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 106 (1996) 729-733
18. Hishikawa K., Oemar B.S., Tanner F.C., Nakaki T., Fujii T., and Luscher T.F. Overexpression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 100 (1999) 2108-2112
19. Allen J.T., Knight R.A., Bloor C.A., and Spiteri M.A. Enhanced insulin like growth factor binding protein 2 (connective tissue growth factor) expression in patients with idiopathic pulmonary fibrosis and pulmonary sarcodiasis. Am J Respir Cell Mol Biol 21 (1999) 693-700
20. Ito Y., Aten J., Bende R.J., et al. Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 53 (1998) 853-861
21. Igarashi A., Hayashi N., Nashiro K., and Takehara K. Differential expression of connective tissue growth factor gene induces apoptosis in human aortic smooth muscle cells. Circulation 25 (1998) 143-148
22. Uzumcu M., Al Homsi M.F., Ball D.K., et al. Localization of connective tissue growth factor in human uterine tissues. Mol Hum Reprod 6 (2000) 1093-1098
23. Weston G., Trajstman A.C., Gargett C.E., Manuelpillai U., Vollenhoven B.J., and Rogers P.A.W. Fibroids display and anti-angiogenic pattern gene expression profile when compared with adjacent myometrium. Mol Hum Reprod 9 (2003) 541-549
24. Palomba S., Affinito P., Tommaselli G.A., and Nappi C. A clinical trial on the effects of tibolone association with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata. Fertil Steril 70 (1998) 111-118
25. Wiznitzer A., Marbach M., Hazum E., Insler V., Sharoni Y., and Levy J. Gonadotropin releasing hormone specific binding sites in uterine leiomyomata. Biochem Biophys Res Commun 152 (1988) 1326-1331
26. Chegini N., Rong H., Dou Q., Kipersztok S., and Williams R.S. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. J Clin Endocrinol Metab 81 (1996) 3215-3221
27. Lee B.S., and Nowak R.A. Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-β3 (TGF-β3) and altered responses to the antiproliferative effects of TGF-β. J Clin Endocrinol Metab 86 (2001) 913-920
28. Frazier K.S., Williams S., Kothapalli D., Klapper H., and Grotendorst G.R. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 107 (1996) 404-411
29. Di Lieto A., De Falco M., Staibano S., et al. Effects of gonadotropin-releasing hormone agonists on uterine volume and vasculature and on the immunohistochemical expression of basic fibroblast growth factor (bFGF) in uterine leiomyomas. Int J Gynecol Pathol 22 (2003) 353-358